Further uncertainty for biotech/agritech patent applicants
Are products exclusively obtained by essentially biological processes patentable at the EPO?
Read more
Patenting Mobile Apps
Richard Bray and Samuel Bird discuss the patentability of mobile apps.
Read more Eli Lilly v Genentech
Eli Lilly v Genentech: the question of SPCs based on third party MAs is referred to the CJEU.
Read more
Patentability of products obtained from biological processes
After years of controversy, the Technical Board of Appeal (TBA) of the EPO has recently decided that products obtained by essentially biological processes can be patent protected (T1063/18).
Read more
Missing the target with functional claim language
What’s the problem with ‘functional limitations’?
Read more
New Guidance on Patent Eligibility in the USA
The United States Patent and Trademark Office (USPTO) recently announced revised guidelines for evaluating patent applications for subject-matter eligibility. The new guidance took effect from 7 January 2019, with the aim of helping the 8,500 patent examiners and administrative patent judges at the USPTO make clear and consistent decisions concerning inventions which are on the borderline of the patent system.
Read more A tale of broccoli, tomatoes and peppers
After years of controversy, the Technical Board of Appeal (TBA) of the EPO has recently decided that products obtained by essentially biological processes can be patent protected
Read more
Warner-Lambert feels the pain in the Supreme Court
In a recent decision (Warner-Lambert Company LLC v Generics Ltd t/a Mylan and Actavis Group), the Supreme Court has rejected an appeal by Warner-Lambert against a High Court and subsequent Court of Appeal decision regarding the invalidity and infringement of their patent.
Read more
SPC you later to drug-device combinations
On 25 October 2018 the Court of Justice of the European Union (CJEU) handed down its judgment on the case C-527/17 relating to supplementary protection certificates (SPCs) for drug-device combination products. In brief, the CJEU decided that the drug-device combination product in question was not eligible for an SPC. This article considers the background and implications of the judgment.
Read more
A Patent Guide to Christmas Day
Christmas Day is just around the corner, and here at Appleyard Lees we have accumulated some of the best IP ever published to help you enjoy the holidays and have the perfect festive season. Relax as we take you through your perfect patent-filled Christmas day.
Read more
Women in IP – Flexible working and career breaks
On the 22nd November 2018, the Women in IP group, a part of the IP Inclusive initiative, held its third annual panel discussion.
Read more
